MDT Medtronic plc

  1. Stocks
  2. Healthcare
  3. NYSE: MDT

Price (delayed)

$116.58

Market cap

$156.92B

P/E Ratio

44.33

Dividend/share

$2.28

EPS

$2.63

Enterprise value

$180.51B

Sector: Healthcare
Industry: Medical Devices
Website: http://www.medtronic.com/

Highlights

Medtronic's quick ratio has decreased by 19% YoY but it has increased by 19% from the previous quarter
The price to earnings (P/E) is 41% higher than the last 4 quarters average of 31.4 and 36% higher than the 5-year quarterly average of 32.7
The EPS has declined by 24% year-on-year and by 20% since the previous quarter

Key stats

What are the main financial stats of MDT
Market
Shares outstanding
1.35B
Market cap
$156.92B
Enterprise value
$180.51B
Valuations
Price to earnings (P/E)
44.33
Price to book (P/B)
3.12
Price to sales (P/S)
5.62
EV/EBIT
46.93
EV/EBITDA
27.68
EV/Sales
6.48
Earnings
Revenue
$27.87B
EBIT
$3.85B
EBITDA
$6.52B
Free cash flow
$4.75B
Per share
EPS
$2.63
Free cash flow per share
$3.53
Book value per share
$37.32
Revenue per share
$20.73
TBVPS
$26.97
Balance sheet
Total assets
$95.89B
Total liabilities
$45.57B
Debt
$30.01B
Equity
$50.16B
Working capital
$13.97B
Liquidity
Debt to equity
0.6
Current ratio
2.16
Quick ratio
1.63
Net debt/EBITDA
3.62
Margins
EBITDA margin
23.4%
Gross margin
64.6%
Net margin
12.7%
Operating margin
12.8%
Efficiency
Return on assets
3.8%
Return on equity
7%
Return on invested capital
8.6%
Return on capital employed
4.6%
Return on sales
13.8%
Dividend
Dividend yield
1.96%
DPS
$2.28
Payout ratio
86.7%

MDT stock price

How has the Medtronic stock price performed over time
Intraday
-1.13%
1 week
-0.2%
1 month
1.7%
1 year
-3.72%
YTD
-0.48%
QTD
-0.48%

Financial performance

How have Medtronic's revenue and profit performed over time
Revenue
$27.87B
Gross profit
$17.99B
Operating income
$3.56B
Net income
$3.54B
Gross margin
64.6%
Net margin
12.7%
The operating income has decreased by 44% YoY and by 11% QoQ
The operating margin has declined by 38% year-on-year and by 10% since the previous quarter
The net income has contracted by 24% YoY and by 20% from the previous quarter
MDT's net margin is down by 20% since the previous quarter and by 16% year-on-year

Growth

What is Medtronic's growth rate over time

Valuation

What is Medtronic stock price valuation
P/E
44.33
P/B
3.12
P/S
5.62
EV/EBIT
46.93
EV/EBITDA
27.68
EV/Sales
6.48
The price to earnings (P/E) is 41% higher than the last 4 quarters average of 31.4 and 36% higher than the 5-year quarterly average of 32.7
The EPS has declined by 24% year-on-year and by 20% since the previous quarter
The stock's price to book (P/B) is 30% more than its 5-year quarterly average of 2.4 and 16% more than its last 4 quarters average of 2.7
MDT's P/S is 37% higher than its 5-year quarterly average of 4.1 and 17% higher than its last 4 quarters average of 4.8
Medtronic's revenue has decreased by 10% YoY

Efficiency

How efficient is Medtronic business performance
The company's return on invested capital fell by 45% YoY and by 11% QoQ
The return on sales has declined by 36% year-on-year and by 10% since the previous quarter
MDT's return on assets is down by 27% year-on-year and by 21% since the previous quarter
Medtronic's return on equity has decreased by 25% YoY and by 20% QoQ

Dividends

What is MDT's dividend history
DPS
$2.28
Dividend yield
1.96%
Payout ratio
86.7%
Recent dividends

Financial health

How did Medtronic financials performed over time
The total assets is 110% greater than the total liabilities
The company's current ratio fell by 22% YoY but it rose by 16% QoQ
Medtronic's quick ratio has decreased by 19% YoY but it has increased by 19% from the previous quarter
MDT's debt is 40% smaller than its equity
Medtronic's debt to equity has increased by 18% YoY and by 5% from the previous quarter
MDT's debt is up by 17% year-on-year and by 4.6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.